11 extractive question-and-answer pairs built from ICMR Standard Treatment Workflow (STW) BREAST CANCER, published by icmr.gov.in. Every answer is a verbatim span of text the source prints, and each row carries the passage it sits in, its offset in that passage, the source quote, the page and the location in the document, so any row can be checked against the original. 11 of the 11 pairs (100.0%) are explanatory questions and 0 restate a figure. 100.00% of rows pass the corpus quality gate.
Use the API URL with your free DD token in notebooks, scripts, and pipelines.
https://www.desidata.in/api/datasets/icmr-standard-treatment-workflow-for-breast-cancer-question-and-answer-dataset/downloadDataset downloads are free. For Python or API downloads, sign in once and create a free DD token; set it as DD_TOKEN or save it in your notebook's secrets. Requests are linked to your account so your download history and counts stay accurate.
# One-time install: pip install desidata
# Set DD_TOKEN in your environment first (create a free token in Profile & settings).
import desidata
df = desidata.load("icmr-standard-treatment-workflow-for-breast-cancer-question-and-answer-dataset")
df.head()Sign in with Google to download.
Usable for analysis, but expect some cleaning before you rely on it.
Consensus Document on Management of Pancreatic Cancer - Question and Answer Dataset
Economy · 268 rows
ICMR Standard Treatment Workflow for Cataract - Question and Answer Dataset
Economy · 27 rows
Neurology Questions from P a R T N E R S - Question and Answer Dataset
Economy · 107 rows
Beginner's Guide for Systematic Reviews - Question and Answer Dataset
Economy · 407 rows
Annual Report 2015-16 by agriwelfare.gov.in - Question and Answer Dataset
Economy · 1,013 rows
Higher Education in India - Question and Answer Dataset
Economy · 1,594 rows
Gender Policy of NABARD - Question and Answer Dataset
Economy · 14 rows
ICAR Annual Report 2025-26 - Question and Answer Dataset
Economy · 1,101 rows
First 10 of 11 rows
| question | answer | context | answer_start | question_type | knowledge_quality_score | source_quote | source_page | source_location | confidence | validation_status |
|---|---|---|---|---|---|---|---|---|---|---|
| What is the full form of PET-CT in medical imaging? | Positron emission tomography- computed tomography scan | Primary systemic therapy ALND: Axillary lymph node dissection CECT: Contrast-enhanced computed tomography ER/PR: Estrogen receptor/Progesterone receptor FISH: Fluorescence in situ hybridization HER2: Human epidermal growth factor receptor 2 IHC: Immunohistochemistry MBC: Metastatic breast cancer PET-CT: Positron emission tomography- computed tomography scan RT: Radiotherapy SLNB: Sentinel lymph node biopsy | 305 | definition | 1.000 | Primary systemic therapy ALND: Axillary lymph node dissection CECT: Contrast-enhanced computed tomography ER/PR: Estrogen receptor/Progesterone receptor FISH: Fluorescence in situ hybridization HER2: Human epidermal growth factor receptor 2 IHC: Immunohistochemistry MBC: Metastatic breast cancer PET-CT: Positron emission tomography- computed tomography scan RT: Radiotherapy SLNB: Sentinel lymph node biopsy | 1 | page=1,block=69 | 0.700 | valid |
| What does HER2 signify in breast cancer pathology? | Human epidermal growth factor receptor 2 | Primary systemic therapy ALND: Axillary lymph node dissection CECT: Contrast-enhanced computed tomography ER/PR: Estrogen receptor/Progesterone receptor FISH: Fluorescence in situ hybridization HER2: Human epidermal growth factor receptor 2 IHC: Immunohistochemistry MBC: Metastatic breast cancer PET-CT: Positron emission tomography- computed tomography scan RT: Radiotherapy SLNB: Sentinel lymph node biopsy | 200 | definition | 1.000 | Primary systemic therapy ALND: Axillary lymph node dissection CECT: Contrast-enhanced computed tomography ER/PR: Estrogen receptor/Progesterone receptor FISH: Fluorescence in situ hybridization HER2: Human epidermal growth factor receptor 2 IHC: Immunohistochemistry MBC: Metastatic breast cancer PET-CT: Positron emission tomography- computed tomography scan RT: Radiotherapy SLNB: Sentinel lymph node biopsy | 1 | page=1,block=69 | 0.700 | valid |
| What does PET-CT stand for in medical imaging? | Positron emission tomography- computed tomography scan | Primary systemic therapy ALND: Axillary lymph node dissection CECT: Contrast-enhanced computed tomography ER/PR: Estrogen receptor/Progesterone receptor FISH: Fluorescence in situ hybridization HER2: Human epidermal growth factor receptor 2 IHC: Immunohistochemistry MBC: Metastatic breast cancer PET-CT: Positron emission tomography- computed tomography scan RT: Radiotherapy SLNB: Sentinel lymph node biopsy | 305 | definition | 1.000 | Primary systemic therapy ALND: Axillary lymph node dissection CECT: Contrast-enhanced computed tomography ER/PR: Estrogen receptor/Progesterone receptor FISH: Fluorescence in situ hybridization HER2: Human epidermal growth factor receptor 2 IHC: Immunohistochemistry MBC: Metastatic breast cancer PET-CT: Positron emission tomography- computed tomography scan RT: Radiotherapy SLNB: Sentinel lymph node biopsy | 1 | page=1,block=69 | 0.700 | valid |
| What does HER2 stand for in breast cancer pathology? | Human epidermal growth factor receptor 2 | Primary systemic therapy ALND: Axillary lymph node dissection CECT: Contrast-enhanced computed tomography ER/PR: Estrogen receptor/Progesterone receptor FISH: Fluorescence in situ hybridization HER2: Human epidermal growth factor receptor 2 IHC: Immunohistochemistry MBC: Metastatic breast cancer PET-CT: Positron emission tomography- computed tomography scan RT: Radiotherapy SLNB: Sentinel lymph node biopsy | 200 | definition | 1.000 | Primary systemic therapy ALND: Axillary lymph node dissection CECT: Contrast-enhanced computed tomography ER/PR: Estrogen receptor/Progesterone receptor FISH: Fluorescence in situ hybridization HER2: Human epidermal growth factor receptor 2 IHC: Immunohistochemistry MBC: Metastatic breast cancer PET-CT: Positron emission tomography- computed tomography scan RT: Radiotherapy SLNB: Sentinel lymph node biopsy | 1 | page=1,block=69 | 0.700 | valid |
| What does HER2 refer to in breast cancer pathology? | Human epidermal growth factor receptor 2 | Primary systemic therapy ALND: Axillary lymph node dissection CECT: Contrast-enhanced computed tomography ER/PR: Estrogen receptor/Progesterone receptor FISH: Fluorescence in situ hybridization HER2: Human epidermal growth factor receptor 2 IHC: Immunohistochemistry MBC: Metastatic breast cancer PET-CT: Positron emission tomography- computed tomography scan RT: Radiotherapy SLNB: Sentinel lymph node biopsy | 200 | definition | 1.000 | Primary systemic therapy ALND: Axillary lymph node dissection CECT: Contrast-enhanced computed tomography ER/PR: Estrogen receptor/Progesterone receptor FISH: Fluorescence in situ hybridization HER2: Human epidermal growth factor receptor 2 IHC: Immunohistochemistry MBC: Metastatic breast cancer PET-CT: Positron emission tomography- computed tomography scan RT: Radiotherapy SLNB: Sentinel lymph node biopsy | 1 | page=1,block=69 | 0.700 | valid |
| What does the abbreviation PET-CT refer to? | Positron emission tomography- computed tomography scan | Primary systemic therapy ALND: Axillary lymph node dissection CECT: Contrast-enhanced computed tomography ER/PR: Estrogen receptor/Progesterone receptor FISH: Fluorescence in situ hybridization HER2: Human epidermal growth factor receptor 2 IHC: Immunohistochemistry MBC: Metastatic breast cancer PET-CT: Positron emission tomography- computed tomography scan RT: Radiotherapy SLNB: Sentinel lymph node biopsy | 305 | definition | 0.980 | Primary systemic therapy ALND: Axillary lymph node dissection CECT: Contrast-enhanced computed tomography ER/PR: Estrogen receptor/Progesterone receptor FISH: Fluorescence in situ hybridization HER2: Human epidermal growth factor receptor 2 IHC: Immunohistochemistry MBC: Metastatic breast cancer PET-CT: Positron emission tomography- computed tomography scan RT: Radiotherapy SLNB: Sentinel lymph node biopsy | 1 | page=1,block=69 | 0.700 | valid |
| What does the abbreviation HER2 stand for? | Human epidermal growth factor receptor 2 | Primary systemic therapy ALND: Axillary lymph node dissection CECT: Contrast-enhanced computed tomography ER/PR: Estrogen receptor/Progesterone receptor FISH: Fluorescence in situ hybridization HER2: Human epidermal growth factor receptor 2 IHC: Immunohistochemistry MBC: Metastatic breast cancer PET-CT: Positron emission tomography- computed tomography scan RT: Radiotherapy SLNB: Sentinel lymph node biopsy | 200 | definition | 0.980 | Primary systemic therapy ALND: Axillary lymph node dissection CECT: Contrast-enhanced computed tomography ER/PR: Estrogen receptor/Progesterone receptor FISH: Fluorescence in situ hybridization HER2: Human epidermal growth factor receptor 2 IHC: Immunohistochemistry MBC: Metastatic breast cancer PET-CT: Positron emission tomography- computed tomography scan RT: Radiotherapy SLNB: Sentinel lymph node biopsy | 1 | page=1,block=69 | 0.700 | valid |
| What does ALND stand for in the context of breast cancer treatment? | Axillary lymph node dissection | Primary systemic therapy ALND: Axillary lymph node dissection CECT: Contrast-enhanced computed tomography ER/PR: Estrogen receptor/Progesterone receptor FISH: Fluorescence in situ hybridization HER2: Human epidermal growth factor receptor 2 IHC: Immunohistochemistry MBC: Metastatic breast cancer PET-CT: Positron emission tomography- computed tomography scan RT: Radiotherapy SLNB: Sentinel lymph node biopsy | 31 | definition | 0.940 | Primary systemic therapy ALND: Axillary lymph node dissection CECT: Contrast-enhanced computed tomography ER/PR: Estrogen receptor/Progesterone receptor FISH: Fluorescence in situ hybridization HER2: Human epidermal growth factor receptor 2 IHC: Immunohistochemistry MBC: Metastatic breast cancer PET-CT: Positron emission tomography- computed tomography scan RT: Radiotherapy SLNB: Sentinel lymph node biopsy | 1 | page=1,block=69 | 0.700 | valid |
| What does the abbreviation ALND stand for? | Axillary lymph node dissection | Primary systemic therapy ALND: Axillary lymph node dissection CECT: Contrast-enhanced computed tomography ER/PR: Estrogen receptor/Progesterone receptor FISH: Fluorescence in situ hybridization HER2: Human epidermal growth factor receptor 2 IHC: Immunohistochemistry MBC: Metastatic breast cancer PET-CT: Positron emission tomography- computed tomography scan RT: Radiotherapy SLNB: Sentinel lymph node biopsy | 31 | definition | 0.900 | Primary systemic therapy ALND: Axillary lymph node dissection CECT: Contrast-enhanced computed tomography ER/PR: Estrogen receptor/Progesterone receptor FISH: Fluorescence in situ hybridization HER2: Human epidermal growth factor receptor 2 IHC: Immunohistochemistry MBC: Metastatic breast cancer PET-CT: Positron emission tomography- computed tomography scan RT: Radiotherapy SLNB: Sentinel lymph node biopsy | 1 | page=1,block=69 | 0.700 | valid |
| What are some symptoms indicating distant spread of breast cancer? | headache, jaundice, dyspnoea, bone pains, ascites | A. Asymmetry of breast or nipple areola or axilla B. Breast lump, bulge, blood vessels prominent C. Colour change of skin or nipple areola D. Deformed breast / nipple areola (nipple retraction), dimpling of skin, Discharge from nipple, Direct spread-skin (satellite nodule, ulcer, skin oedema), chest wall Distant spread - headache, jaundice, dyspnoea, bone pains, ascites CLINICAL BREAST EXAMINATION IMAGING • Bilateral mammogram: for women >30 years • Ultrasound: breast and axilla • MRI breast in selected cases STAGING- T1, T2 N0 N1 Upto Stage 2A no metastatic work up Stage 2B upwards • Chest radiograph • Ultrasound whole abdomen • Bone scan • CECT chest and abdomen • PET-CT (optional) PATHOLOGY • Core needle biopsy (preferred) for type, grade, ER, PR, HER2/neu, Ki-67 • FISH test if HER-2/neu on IHC-2+/ equivocal | 323 | list | 0.820 | Deformed breast / nipple areola (nipple retraction), dimpling of skin, Discharge from nipple, Direct spread-skin (satellite nodule, ulcer, skin oedema), chest wall Distant spread - headache, jaundice, dyspnoea, bone pains, ascites CLINICAL BREAST EXAMINATION IMAGING • Bilateral mammogram: for women >30 years • Ultrasound: breast and axilla • MRI breast in selected cases STAGING- T1, T2 N0 N1 Upto Stage 2A no metastatic work up Stage 2B upwards • Chest radiograph • Ultrasound whole abdomen • Bone scan • CECT chest and abdomen • PET-CT (optional) PATHOLOGY • Core needle biopsy (preferred) for |
Read straight from the file — download or use the API URL for the full dataset.
| 1 |
| page=1,block=7 |
| 0.700 |
| valid |